ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's Labs Q4 Results: Cons PAT jumps 22% to Rs 1,594 crore; Rs 8 per share dividend announced
Dr Reddy's Labs Q4 Results: Dr Reddy's Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period.
Announcement as on 09 May 2025

Dr Reddy’s Labs Q4 Preview: PAT may jump up to 12% YoY, revenue to rise up to 18% on generics business dose
Dr Reddy’s Q4FY25 net profit is expected to grow 1.3–12% YoY, with revenues likely rising 13–18% to ₹7,981–8,424 crore, according to brokerage estimates. Key focus areas include US business and margin outlook.
Announcement as on 08 May 2025

Stocks in news: Bajaj Finance, Ambuja, Ultratech Cement, Dr Reddy's, Adani Total Gas
Shares of Bajaj Finance, Bajaj Finserv, Trent, Ambuja, BPCL and NTPC Green will be in focus as the companies will announce their fourth quarter results.
Announcement as on 29 April 2025

Dr Reddy's to introduce Sanofi's novel drug in India
Dr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing lower respiratory tract disease in newborns caused by RSV. Dr. Reddy's will exclusively promote and distribute Beyfortus in India,
Announcement as on 28 April 2025

Dr Reddy's, Lupin recall products in US due to labelling, manufacturing errors: USFDA
Dr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is recalling an antiepileptic drug due to a labeling mix-up, where infusion bags were incorrectly labeled. Lupin Pharmaceuticals is re
Announcement as on 22 April 2025

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.28
  • 12Day Average: 14.53
  • 20Day Average: 14.06
  • 50Day Average: 13.66
  • 100Day Average: 13.75
  • 150Day Average: 13.77
  • 200Day Average: 13.84

RDY Indicators & signals

Indicator MACD (12,26,9)

14.24, 14.04, 0.26
Indicator MACD is in positive zone

Indicator ADX (14)

10.34, 30.95, 38.1
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Thu Jul 2026 13.89 13.57 to 14.06 -1.63% 1.37 times
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.16 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 0.81 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.35 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.65 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.05 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1.01 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.58 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.1 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.37 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.92 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.23 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top